CASI Pharmaceuticals Inc. (CASI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
1.31
-0.20 (-13.30%)
At close: Sep 26, 2025, 3:59 PM
1.32
0.70%
After-hours: Sep 26, 2025, 07:58 PM EDT

CASI Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.47M 17.08M 47.11M 38.7M
Short-Term Investments
2.62M 13.69M 4.22M 9.87M
Long-Term Investments
1.72M 1.69M 7.46M 40.13M
Other Long-Term Assets
587K 766K 1.06M 2.18M
Receivables
15.35M 10.14M 12.97M 9.8M
Inventory
5.25M 15.88M 6.14M 1.91M
Other Current Assets
2.89M 2.56M 2.98M n/a
Total Current Assets
39.58M 59.34M 73.42M 61.97M
Property-Plant & Equipment
11.36M 11.63M 13.23M 21.82M
Goodwill & Intangibles
238K 1.84M 1.06M 12.2M
Total Long-Term Assets
13.9M 15.92M 22.81M 76.33M
Total Assets
53.67M 75.27M 96.23M 138.3M
Account Payables
2.72M 4.44M 3.29M 4.79M
Deferred Revenue
2.47M n/a 2.62M 2.83M
Short-Term Debt
18.39M n/a n/a n/a
Other Current Liabilities
10.31M 8.44M 8.04M 519K
Total Current Liabilities
36.45M 16.73M 17M 13.19M
Long-Term Debt
n/a 18.89M n/a n/a
Other Long-Term Liabilities
12.84M 13.87M 11.82M 13.22M
Total Long-Term Liabilities
15.37M 34.38M 12.3M 17.15M
Total Liabilities
51.82M 51.1M 29.3M 30.34M
Total Debt
22.14M 21.24M 1.34M 2.17M
Book Value
1.85M 24.16M 66.93M 107.96M
Book Value Per Share
0.12 1.81 4.90 7.93
Common Stock
2K 1K 1K 1.4M
Retained Earnings
-700.08M -660.82M -637.16M -605.64M
Comprehensive Income
-1.77M -1.2M -703K 1.95M
Shareholders Equity
1.85M 24.16M 44.57M 84.5M
Total Investments
4.34M 15.37M 11.69M 50M